Paxillin 抗体 (pSer178)
(1 reference)-
- 抗原 See all Paxillin (PXN) 抗体
- Paxillin (PXN)
-
抗原表位
- pSer178
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This Paxillin antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 预测反应
- Human,Mouse,Rat
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic phosphopeptide derived from human Paxillin around the phosphorylation site of Ser178
- 亚型
- IgG
- Top Product
- Discover our top product PXN Primary Antibody
-
anti-Paxillin (PXN) (AA 201-461) antibody
PXN 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 347-578) antibodyPXN 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 1-262) antibodyPXN 适用: 人 WB, PLA 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 327-568) antibodyPXN 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 456-472) antibodyPXN 适用: 人, 小鼠, 大鼠 WB, IHC (p), ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 456-472), (C-Term) antibodyPXN 适用: 人, 小鼠, 大鼠 WB, IHC (p), ICC, IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (pTyr118) antibodyPXN 适用: 人, 小鼠, 大鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 1-262) antibodyPXN 适用: 人 WB, IP 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (AA 28-45) antibodyPXN 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Paxillin (PXN) (pTyr118) antibodyPXN 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
-
: "Oleanolic acid stimulation of cell migration involves a biphasic signaling mechanism." in: Scientific reports, Vol. 12, Issue 1, pp. 15065, (2022) (PubMed).
-
: "Oleanolic acid stimulation of cell migration involves a biphasic signaling mechanism." in: Scientific reports, Vol. 12, Issue 1, pp. 15065, (2022) (PubMed).
-
- 抗原
- Paxillin (PXN)
- 别名
- Paxillin (PXN 产品)
- 别名
- AW108311 antibody, AW123232 antibody, Pax antibody, CG18061 antibody, CG18576 antibody, CG31794 antibody, CT40481 antibody, CT42454 antibody, DPaxillin antibody, DPxn antibody, DPxn37 antibody, Dmel\\CG31794 antibody, Dpax antibody, DpaxA antibody, PDLP antibody, dPax antibody, pax antibody, wu:fw71f12 antibody, PXN antibody, LOC100220858 antibody, paxillin antibody, Paxillin antibody, paxillin S homeolog antibody, paxillin a antibody, PXN antibody, Pxn antibody, Pax antibody, pxn.S antibody, pxna antibody, LOC696336 antibody, pxn antibody
- 背景
-
Synonyms: PXNphospho S178, Paxillin phospho S178, Paxillin phospho Ser178, p-Paxillin Ser178, Paired box protein Pax 1, PAX 1, PAX1, Paxillin alpha, PXN, PXN protein, FLJ16691, FLJ23042, FLJ16691, PAXI_HUMAN, Paxillin, PXN protein.
Background: Paxillin is a 64 kDa cytoskeletal adapter protein involved in organisation and function of focal adhesions, which are critical to cell adhesion and migration. This in turn plays a role in a wide variety of processes including embryogenesis, organogenesis, wound repair, inflammation and cancer. Paxillin contains LD motifs, LIM domains, SH3 and SH2 binding domains that serve as docking sites for cytoskeletal proteins, tyrosine kinases (e.g., FAK, Pyk 2, Src), serine/threonine kinases, GTPase activating proteins and other adaptor proteins (e.g., Actin, Vinculin, Crk).
- 基因ID
- 5829
- 途径
- MAPK Pathway, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
-
